CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2025

Jun 6, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-06-02

Reporting Person: Andrews William T. (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase common stock	$24.90	2032-06-02	Common Stock (124447)		Direct
Restricted Stock Units	$		Common Stock (15261)		Direct

Footnotes

F1: Derivative Securities vest in five annual tranches beginning on June 2, 2026.

F2: Shares of common stock will be delivered to the Reporting Person upon vesting.

F3: Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.